Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

3.45
-0.1100-3.09%
Post-market: 3.510.0600+1.74%19:44 EDT
Volume:898.03K
Turnover:3.15M
Market Cap:149.37M
PE:-4.45
High:3.61
Open:3.52
Low:3.44
Close:3.56
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:36.46M
Volume Ratio:1.04
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-878.65
PE(LYR):-2.58

Loading ...

NRx Pharmaceuticals closes USD 22.3 million follow-on stock offering at USD 3.5 a share

Reuters
·
Jun 05

NRX Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

THOMSON REUTERS
·
Jun 05

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

BUZZ-NRx Pharma dives on deep-discounted share offering

Reuters
·
Jun 03

NRx Pharmaceuticals prices 5,714,286-share follow-on at $3.5 per share

Reuters
·
Jun 03

NRX Pharmaceuticals - Prices Public Offering of 5.71 Mln Shares at $3.5 per Share

THOMSON REUTERS
·
Jun 03

Top Premarket Decliners

MT Newswires Live
·
Jun 03

Stocks to Watch: GameStop, GitLab, NRx Pharmaceuticals, Xos

Dow Jones
·
Jun 03

NRx Pharmaceuticals Shares Sink on Stock Offering

Dow Jones
·
Jun 03

NRx Pharmaceuticals plans underwritten public offering of common stock

Reuters
·
Jun 03

NRX Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Jun 03

NRx partner Emobot reports pooled clinical validation of EMOCARE depression monitoring tool at ASCP 2026

Reuters
·
May 28

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

GlobeNewswire
·
May 27

NRX Pharmaceuticals (Nasdaq:Nrxp) Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 18

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
May 18

NRX Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

NRX Pharmaceuticals Q1 EPS $(0.04) Up From $(0.34) YoY, Sales $1.068M

Benzinga Earnings
·
May 16

NRx Pharma Q1 FY26 net loss narrows to $1.43 million; revenue turns to $1.07 million

Reuters
·
May 16

NRX Pharmaceuticals Inc expected to post earnings of 29 cents a share - Earnings Preview

Reuters
·
May 15